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Study objective: To investigate the effect of the voluntary folate fortification policy in Australia on serum
folate and total plasma homocysteine (tHcy) concentrations.
Design: Population based cohort study.
Setting: Perth, Western Australia.
Participants:Men and women aged 27 to 77 years (n = 468), who were originally randomly selected from
the Perth electoral roll. The cohort was surveyed in 1995/96 before widespread introduction of folate
fortification of a variety of foods, and followed up on two occasions, firstly in 1998/99 and again in
2001, when a moderate number of folate fortified foods were available. Subjects with abnormal serum
creatinine concentrations at baseline were excluded from this analysis.
Main results: Repeated measures analysis of variance was used to determine changes in serum folate and
tHcy over the three surveys and to assess whether time trends were related to age, sex, MTHFR C677T
genotype, or consumption of folate fortified foods. An increase (38%) in mean serum folate (p,0.0005)
and a decrease (21%) in mean tHcy (p,0.0005) were seen after introduction of the voluntary folate
fortification policy in Australia. Serum folate was consistently higher (p = 0.032) and tHcy was consistently
lower (p = 0.001) in subjects who consumed at least one folate fortified food compared with subjects who
did not consume any folate fortified foods in the previous week. The time related changes in serum folate
and tHcy were affected only by intake of folate fortified foods (p,0.0005) and not by any other measured
variables including age, sex, or MTHFR genotype.
Conclusion: Voluntary fortification of foods with folate in Australia has been followed by a substantial
increase in serum folate and decrease in tHcy in the general population.
V
oluntary folate fortification was recommended by an
expert panel of Australia’s National Health and Medical
Research Council in 1994 in response to the convincing
body of evidence that folate supplementation reduced the
incidence of neural tube defects (NTDs).1 In June 1995
Australia’s National Food Authority permitted the voluntary
fortification of flour, bread, savoury biscuits, breakfast
cereals, pasta, yeast extracts (a popular spread for bread in
Australia), fruits and vegetable juices, and meal replacements
with folate to 100 mg folate per serving.2 Manufacturers are
not required to fortify their products. In 1998, supplemental
foods such as folate fortified milk products were added to the
list and temporary permission was given for a health claim
describing the link between adequate maternal dietary folate
intake and a reduction in risk of NTDs developing in
pregnancy. This is currently the primary means by which
folate fortified products are identified and promoted nation-
ally.3
There has been a recent and sustained decrease in the
prevalence of NTDs in Western Australia that is thought to be
attributable to increased peri-conceptional intake of folate
supplement in response to health promotion campaigns and
the voluntary folate fortification policy. The total frequency of
NTDs (births plus terminations) was comparatively constant
for the period 1980–1995 (average of 1.96 per 1000 births)
but decreased by 30% to 1.38 per 1000 for 1996–2000.4
Increased intake of folate may have a wider impact beyond
reducing the risk of NTDs. There is sound epidemiological
evidence of an independent, dose related association between
total plasma homocysteine (tHcy) and morbidity and
mortality from vascular disease.5–7 Folate decreases tHcy
effectively at doses that could be achieved by increased intake
of folate from folate fortified and folate rich foods.8–12 If
widely shared in the community, modest decreases in tHcy
could have a large impact on the population wide burden of
vascular disease, assuming the relation between tHcy and
vascular disease is causal.
A mandatory folate fortification policy in the USA was
associated with a substantial increase in serum folate and
decrease in tHcy in a population of middle aged and older
adults.8 Other countries, including Australia and the United
Kingdom have adopted a voluntary folate fortification policy
but it is not known whether this is adequate to increase
serum folate and reduce plasma homocysteine values
significantly. We therefore investigated the effect of the
voluntary folate fortification policy in Australia on serum
folate and tHcy in a population based cohort. The cohort was
surveyed in 1995/96 before widespread introduction of folate
fortification, and followed up on two occasions, firstly in
1998/99, when some folate fortified foods were available, and
again in 2001, when about 50% of breakfast cereals sold, 18%
of breads sold, the two leading brands of yeast extract, and
small proportions of other foods, including milk, were
fortified with folate.3 13
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METHODS
Participants and study design
The participants were men and women aged 27 to 77 years
from Perth, the capital city in Western Australia. Subjects
were originally recruited for the 1989 Australian National
Heart Foundation Perth risk factor prevalence survey.14 This
was a stratified random survey of 2000 people drawn from
the electoral roll for Perth. Enrolment to vote is compulsory
for Australian citizens. Repeat electoral roll and death record
matching in May 1995 established a current address for 1807
living subjects, and of these 1111 (61%) agreed to take part in
the carotid ultrasound disease assessment study (CUDAS)
between June 1995 and December 1996.15 Subjects were
followed up on two occasions, firstly between September
1998 and December 1999, and again from October to
December 2001. Subjects with abnormal serum creatinine
(.120 mmol/l men, .100 mmol/l women) concentrations at
baseline were considered likely to have chronic renal disease
and were excluded from this analysis. Data presented here
are for 468 subjects who participated in all three surveys.
Ethical issues
The human research ethics committee at the University of
Western Australia approved the study. Informed consent was
obtained from all participants.
Biochemical analyses
At each survey venous blood samples were collected from all
participants after an overnight fast. Plasma and serum were
separated by centrifugation shortly after venipuncture and
transported to the laboratory in ice cooled containers. Total
plasma homocysteine concentration was determined by high
performance liquid chromatography using the method of
Araki and Sako.16 As there is no definition of ‘‘high’’ tHcy
concentration we used the often used threshold of.13 mmol/
l, which approximately defines the top quartile of tHcy in our
population.15 Serum folate was determined by immunoassay
using an ACS:180 (Bayer Diagnostics) in the first two
surveys. In the final survey serum folate was determined by
immunoassay using a DPC Immulite 2000 as the ACS:180
method was no longer available. A random subset of samples
(n=98) from the first two surveys were re-measured via the
DPC Immulite 2000 method. Results from the two methods
agreed well with analysis yielding the following regression
equation: y (ACS:180) = 0.98x (DPC Immulite 2000)
+1.444 mg/l; r=0.95; p,0.0005. This calibration equation
enabled comparison of results across all three surveys. A
serum folate of ,6 mg/l was defined as ‘‘low’’.17 DNA was
extracted by the salt phenol chloroform method from the
cells of the buffy coat. Methylenetetrahydrofolate reductase
MTHFR C677T genotype was determined by Hinfl digestion of
the PCR products.18
Dietary and lifestyle assessment
Dietary intakes of naturally occurring folate, vitamin B6, and
vitamin B12 were estimated at baseline (1995/96) and follow
up 1 (1998/99) by a self administered semi-quantitative food
frequency questionnaire.19 20 At follow up 2 (Dec 2001)
dietary intake of folate was estimated using a previously
validated rapid dietary assessment tool that collected
information on the use of the types and brand of foods that
may be fortified with folate.21
Statisitical analyses
Pearson’s correlation was used to determine the relation
between serum folate and tHcy. Paired sample t tests were
used to determine if there was a difference in mean tHcy,
serum folate, and dietary intake of naturally occurring folate,
vitamin B6, and vitamin B12 between surveys. Repeated
measures analysis of variance was used to determine if there
were changes in serum folate and tHcy over the three surveys
and (via interaction terms) whether time trends were related
to age, sex, MTHFR genotype, or consumption of folate
fortified foods. Frequencies of categorical variables were
compared using McNemar’s test and Cochran’s Q test. We
used logistic regression to explore associations between use
of folate fortified foods and age, sex, use of folate supple-
ments, smoking, and socioeconomic status as estimated from




The study population consisted of 219 women and 249 men,
ranging in age at baseline from 27 to 77 years, with a mean
age of 53 years. They were a sub-cohort of the overall CUDAS
general population, whose clinical characteristics have been
described previously.15
Serum folate and total plasma homocysteine
Table 1 shows the folate and tHcy data at baseline and follow
up visits. The Pearson correlation coefficient (r) for serum
folate and tHcy was consistent across the surveys at about
20.3 (p,0.0005). Repeated measures analysis showed an
increase (38%) in mean serum folate (p,0.0005) and a
decrease (21%) in mean tHcy (p,0.0005) after introduction
of the voluntary folate fortification policy in Australia
(table 1). The percentage of subjects with low serum folate
(,6 mg/l) decreased from 39% at baseline to 17% at follow up
2 (p,0.0005). The percentage of subjects with high tHcy
(.13 mmol/l) decreased from 29% at baseline to 10% at
follow up 2 (p,0.0005).
Figure 1 shows the distribution of serum folate concentra-
tion at baseline, and follow up visits 1 and 2 for the whole
cohort (A) and when the 152 subjects who reported taking
folate supplements at any of the surveys are excluded (B).
Table 1 Serial changes in serum folate and total plasma homocysteine concentrations after voluntary folate fortification in
Australia in a population based cohort
Variable Baseline Follow up 1
Compared with
baseline* Follow up 2
Compared with
follow up 1* Trend over time
Serum folate (mg/l) (SD) 7.4 (4.5) 9.8 (5.1) p,0.0005 10.2 (4.5) p = 0.124 p,0.0005
Serum folate ,6 mg/l 39% 21% p,0.0005 17% P=0.005 p,0.0005
tHcy (mmol/l) (SD) 11.7 (3.6) 9.6 (3.3) p,0.0005 9.3 (3.7) p = 0.004 p,0.0005
tHcy .13 mmol/l 29% 11% p,0.0005 10% P=0.755 p,0.0005
Pearson correlation between serum
folate and tHcy
r=20.26 r=20.32 r =20.31
% Use of folate supplements 15.4 10.7 p=0.020 20.7 p,0.0005 p,0.0005
n =468. *Paired sample t test. tHcy, total plasma homocysteine.
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Figure 2 shows similar distributions of tHcy for the whole
cohort (A) and for the cohort excluding users of supplements
(B). The figures show the clear upward shift in the
distribution of serum folate from baseline to the follow up
surveys, and the downward shift in tHcy across the whole
cohort and for the cohort excluding users of supplements.
The use of dietary supplements containing folate was
greater at follow up 2 compared with baseline (table 1).
However, we did not determine how long subjects had been
using these vitamin supplements and only 13 subjects (2.8%)
reported using supplements at all three surveys.
Intake of folate fortified foods
The estimated mean dietary folate from naturally occurring
sources was about 300 mg/day and did not differ significantly
from the baseline survey to follow up 1 (paired sample t test,
p=0.65). Similarly, the dietary intake of naturally occurring
vitamin B6 and vitamin B12 did not differ significantly from
the baseline survey to follow up 1 (paired sample t test: B6
p=0.43, B12 p=0.99). The estimated dietary intake of folate
from fortified sources only at follow up 2 was 65 mg/day. Over
half (57%) of the cohort reported consumption of a folate
fortified breakfast cereal and 52% reported consumption of a
folate fortified yeast extract (for example, Vegemite and
Marmite) in the week before the survey. Only 1% of the
cohort reported consuming folate fortified bread and 7% of
the cohort reported consuming folate fortified milk.
Subgroup analyses
There was a consistently higher mean serum folate for
women compared with men (p=0.001). Conversely, the tHcy
was higher for men than women (p,0.0005). The survey by
sex interaction was not significant for either serum folate or
tHcy.
Mean serum folate was not significantly different for
different age groups (p=0.126). However, mean tHcy
increased consistently with increasing age (p,0.0005). The
survey by age interaction was not significant for either serum
folate or tHcy.
There was a significant difference in serum folate
concentrations across MTHFR genotypes (p=0.017) with
the homozygous subjects (TT—comprising 10% of the cohort)
having a consistently lower serum folate than the hetero-
zygotes (CT—comprising 48% of the cohort) or subjects with
the wild type gene (CC—comprising 42% of the cohort).
However, the MTHFR genotype-time interaction was not
significant for serum folate with a comparable increase in
mean serum folate among the three genotypes. Similarly, the
TT subjects had a consistently higher tHcy than the CT or CC
subjects (p=0.021) but had a comparable decrease in mean
tHcy concentrations over the survey time. The MTHFR
genotype-time interaction was of borderline significance for
tHcy (p=0.079).
Serum folate was consistently higher (p=0.032) and tHcy
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Figure 1 Serum folate concentrations
after voluntary folate fortification in
Australia in a population based cohort
(A) and in the cohort when supplement
users are excluded (B).
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at least one folate fortified food compared with subjects who
did not consume folate fortified foods in the previous week.
The time by use of folate fortified foods interaction was
highly significant for serum folate (p,0.0005) and tHcy
(p,0.0005).
Factors related to the use of folate fortified foods
We explored, by binary logistic regression, the relation
between certain demographic, lifestyle, and socioeconomic
factors and use of folate fortified foods. None of the variables
sex, age, smoking status, use of folate supplements, and
socioeconomic status was significantly related to the use of
folate fortified foods.
DISCUSSION
Our findings suggest that voluntary fortification of foods
with folate in Australia has had a significant beneficial effect
on serum folate and tHcy concentrations in the population.
In our cohort of 468 men and women, mean serum folate
increased significantly, by 38%, and mean tHcy decreased
significantly, by 21%, after voluntary fortification was
implemented. The proportion of subjects with low serum
folate or high tHcy decreased by more than half. As compared
with the successful results of mandatory folate fortification
policy in the USA,8 this is the first study, to our knowledge,
that has shown that even a voluntary folate fortification
policy can be followed by a substantial increase in serum
folate and decrease in tHcy in the general population.
The estimated mean dietary intake of folate measured at
baseline was similar to that seen in the 1995 Australian
national nutrition survey (NNS)23 and did not differ
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Figure 2 Plasma homocysteine
concentrations after voluntary folate
fortification in Australia in a population
based cohort (A) and in the cohort
when supplement users are excluded
(B).
Key points
N The mandatory folate fortification policy in the USA has
been followed by increased blood folate concentrations
and decreased plasma homocysteine in middle aged
and older persons.
N Australia, New Zealand, the United Kingdom, and
other European countries currently have a voluntary
folate fortification policy, but it is not known whether
this is sufficient to increase folate status and reduce
plasma homocysteine in the general population.
N Voluntary fortification of foods with folate in Australia
has been followed by a significant increase in serum
folate and decrease in plasma homocysteine in this
community.
N Assuming a causal relation between plasma homo-
cysteine and vascular disease, the observed changes
might eventually translate into reductions in ischaemic
heart disease and stroke of 13% and 20% respectively.
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No adjustments were made to the nutrient database between
our surveys to account for fortification of foods with folate.
Thus our data show that there was no significant difference
in folate intake from naturally occurring sources and suggest
that any change in folate status is the result of folate added to
the diet as part of the voluntary fortification policy in
Australia. Indeed, subjects who consumed at least one folate
fortified food per week had a greater increase in serum folate
and a greater decrease in tHcy than subjects who did not use
folate fortified foods. It is important to emphasise here that
subjects did not identify themselves as users of folate fortified
foods; rather they were asked to complete a rapid food
frequency questionnaire and to show the type and brand
names of the foods they ate. The questionnaire made no
reference to folate but captured information that allowed us
to identify which subjects were users of folate fortified foods.
The time related changes in serum folate and tHcy were
related only to intake of folate fortified foods (p,0.005) and
not to age, sex, or MTHFR genotype.
We explored the relation between use of these foods and a
number of sociodemographic and lifestyle factors, but none
of the factors we examined (age, sex, socioeconomic status,
use of folate supplements, and smoking status) was related
to the use of folate fortified foods. This suggests that such use
is widespread in the community and not restricted to any
particular age or socioeconomic group, although it remains
possible that other factors that we did not explore may
differentiate users of folate fortified food from non-users.
The reported use of dietary supplements containing folate
was irregular. While the proportion using supplements at
follow up 2 was greater than at baseline only 2.8% reported
using supplements at all three surveys. The small number of
subjects reporting regular use of supplements may explain
why there is little difference in serum folate when the
distribution for the entire cohort is compared with the
distribution for the cohort with subjects using supplements
containing folate at any of the three surveys are removed.
While voluntary folate fortification in Australia came into
effect in June 1995, the response by food manufacturers to
the new policy has been modest.13 We found the greatest
increase in serum folate and decline in tHcy from baseline to
follow up 1, at a time when only some folate fortified foods
were available. However, the first foods to be fortified with
folate were breakfast cereals and Lawrence et al13 reported
that in June 1999 (towards the end of follow up 1) 50% of
breakfast cereals sold were fortified with folate. Breakfast
cereal was the most frequently used folate fortified food in
our cohort, which may explain why we observed a greater
increase in serum folate and decline in tHcy between baseline
and follow up 1 than with between follow up 1 and follow up
2.
The reported increases in serum or plasma folate under a
mandatory folate fortification policy in the USA (5.4 mg/l),
Canada (3.8 mg/l), and Chile (7.2 mg/l) are appreciably greater
than the measured increase in serum folate under the
voluntary folate fortification policy in Australia.8 24 25
However, the decrease in plasma homocysteine in Australia
has been comparable to that reported in the other countries,
which may suggest a threshold effect on homocysteine
lowering from increased folate intake in the general popula-
tion. A mandatory folate fortification policy in Australia is
currently being considered by Food Standards Australia New
Zealand (the bi-national independent statutory authority
that develops food standards that apply to all foods produced
or imported for sale in Australia and New Zealand). Under
the voluntary folate fortification policy this study observed a
greater increase in serum folate in users of folate fortified
foods. A mandatory policy, which should reach a greater
proportion of the population, is likely to result in a wider
spread increase in serum folate. It will be interesting to see
whether this results in a further decrease in homocysteine
concentrations.
A daily supplement of 400 mg folate is reported to achieve
maximum lowering of tHcy.12 Dietary modelling based on
data from the 1995 NNS predicted that mandatory fortifica-
tion to 50% of the recommended daily intake of cereals, juice,
and yeast extract would result in women aged 15–49 years
consuming an additional 250 mg of folate per day,26 with men
expected to consume even more. Only a limited proportion of
the permitted foods have been fortified under the voluntary
folate fortification policy in Australia, and our cohort
consumed less than a third of the anticipated mean increase
in daily intake of folate from fortified foods predicted from
the modelling of mandatory fortification described above.
Thus there is even greater potential to raise serum folate in
our population with wider adoption of folate fortification in
Australia.
Although the cardiovascular benefit of reducing tHcy is
unconfirmed, on the basis that the association between tHcy
and vascular disease is causal, Wald et al estimated that a
3 mmol/l decrease in tHcy would result in a reduction of 16%
in ischaemic heart disease and of 24% in stroke.7 In this study
a decline in mean tHcy of 2.4 mmol/l was seen after the
introduction of voluntary folate fortification in Australia. If
homocysteine proves to be a cause of vascular disease, then
the voluntary folate fortification policy in Australia would be
expected eventually to have a measurable impact on
cardiovascular disease. The growing availability of folate
fortified foods points to the potential of folate fortification to
decrease homocysteine in the community still further.
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Policy implications
N Australia, New Zealand, the United Kingdom, and
other European countries currently have a voluntary
folate fortification policy.
N This paper shows that the voluntary fortification of
foods with folate in Australia has been followed by a
significant increase in serum folate and decrease in
plasma homocysteine in this community. The increase
in serum folate and decrease in tHcy was greater in
subjects who consumed at least one folate fortified food
per week than subjects who did not use folate fortified
foods.
N Only a limited proportion of the permitted foods have
been fortified under the voluntary folate fortification
policy in Australia. Thus, there is even greater potential
to raise serum folate in our population with wider
adoption of folate fortification in Australia.
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